The Aperio Blog
Inspection Readiness Fact Sheet
Aperio Clinical Outcomes has extensive experience in managing inspections for regulatory submissions and addressing the requirements of multiple regulatory agencies, including FDA, EMA, MHRA, BfArM and DEA. Tony Bumarch, VP Global Quality Assurance, has held senior QA roles for both sponsors, sites and CROs and has been a part of more than 10 agency inspections for regulatory submissions.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.
In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.
Aperio Clinical Outcomes.
We make it clear.
